Ziccum Ab Stock Short Ratio
| ZICC Stock | SEK 0.84 0.05 6.33% |
Ziccum AB fundamentals help investors to digest information that contributes to Ziccum AB's financial success or failures. It also enables traders to predict the movement of Ziccum Stock. The fundamental analysis module provides a way to measure Ziccum AB's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ziccum AB stock.
Ziccum |
Ziccum AB Company Short Ratio Analysis
Ziccum AB's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, Ziccum AB has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The short ratio for all Sweden stocks is 100.0% higher than that of the company.
Did you try this?
Run Equity Valuation Now
Equity ValuationCheck real value of public entities based on technical and fundamental data |
| All Next | Launch Module |
Ziccum Fundamentals
| Return On Equity | -0.98 | |||
| Return On Asset | -0.52 | |||
| Current Valuation | 2.01 M | |||
| Shares Outstanding | 13.81 M | |||
| Shares Owned By Insiders | 25.53 % | |||
| Price To Book | 0.81 X | |||
| Price To Sales | 2,383 X | |||
| Gross Profit | 17 K | |||
| EBITDA | (20.27 M) | |||
| Net Income | (21.14 M) | |||
| Cash And Equivalents | 25.71 M | |||
| Cash Per Share | 2.62 X | |||
| Total Debt | 1.43 M | |||
| Debt To Equity | 0.06 % | |||
| Current Ratio | 9.62 X | |||
| Book Value Per Share | 2.12 X | |||
| Cash Flow From Operations | (16.1 M) | |||
| Earnings Per Share | (2.16) X | |||
| Beta | 1.89 | |||
| Market Capitalization | 46.87 M | |||
| Total Asset | 36.9 M | |||
| Z Score | 19.2 | |||
| Net Asset | 36.9 M |
About Ziccum AB Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ziccum AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ziccum AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ziccum AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Ziccum Stock Analysis
When running Ziccum AB's price analysis, check to measure Ziccum AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ziccum AB is operating at the current time. Most of Ziccum AB's value examination focuses on studying past and present price action to predict the probability of Ziccum AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ziccum AB's price. Additionally, you may evaluate how the addition of Ziccum AB to your portfolios can decrease your overall portfolio volatility.